Company profile

CASI Pharmaceuticals, Inc.

CASIF · OTC (Exact normalized legal-name match to SEC CIK 0001962738. Entity resolved by asset-pipeline-v2.)

Share price · CASIF

$0.14+0.00 (+0.00%) 3M

close as of 2026-08-18 · 24h delayed · vol 2K

Loading chart…

Prices are end-of-day (EOD), delayed by 24 hours · Unadjusted for historical splits · Data via Databento

Assets

(2 total)
2Total Assets
1Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 2 of 2 assets
Target & Modality
melphalan hydrochloride (Evomela)
Approved
DNA (guanine N7 position)Small molecule
Multiple Myeloma
CID-103No recent activity
Phase 1
CD38Monoclonal antibody
Multiple Myeloma

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Insider transactions

Research

Unlock insider transactions

Research includes SEC Form 4 insider transactions — filed buys, sells, awards and exercises linked to the underlying filings.

Institutional holders

Research

Unlock institutional holders

Research includes quarterly SEC 13F institutional ownership — top holders, aggregate positions and quarter-over-quarter context.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.